228 related articles for article (PubMed ID: 23274284)
1. Heart failure with preserved ejection fraction: current understanding and emerging concepts.
Liu Y; Haddad T; Dwivedi G
Curr Opin Cardiol; 2013 Mar; 28(2):187-96. PubMed ID: 23274284
[TBL] [Abstract][Full Text] [Related]
2. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
[TBL] [Abstract][Full Text] [Related]
3. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
[TBL] [Abstract][Full Text] [Related]
4. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
5. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
[TBL] [Abstract][Full Text] [Related]
6. Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
From AM; Borlaug BA
Cardiovasc Ther; 2011 Aug; 29(4):e6-21. PubMed ID: 20370792
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology-based novel pharmacotherapy for heart failure with preserved ejection fraction.
Konstantinou DM; Chatzizisis YS; Giannoglou GD
Pharmacol Ther; 2013 Nov; 140(2):156-66. PubMed ID: 23792088
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiology of heart failure with preserved ejection fraction and its therapeutic implications.
Fontes-Carvalho R; Leite-Moreira A
Rev Port Cardiol; 2009 Jan; 28(1):63-82. PubMed ID: 19388494
[TBL] [Abstract][Full Text] [Related]
9. Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients.
Jefferies JL; Bartone C; Menon S; Egnaczyk GF; O'Brien TM; Chung ES
Circ Heart Fail; 2013 Jul; 6(4):733-9. PubMed ID: 23735537
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing heart failure with preserved ejection fraction.
Becher PM; Lindner D; Fluschnik N; Blankenberg S; Westermann D
Expert Opin Med Diagn; 2013 Sep; 7(5):463-74. PubMed ID: 23930995
[TBL] [Abstract][Full Text] [Related]
11. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
Tschöpe C; Birner C; Böhm M; Bruder O; Frantz S; Luchner A; Maier L; Störk S; Kherad B; Laufs U
Clin Res Cardiol; 2018 Jan; 107(1):1-19. PubMed ID: 29018938
[TBL] [Abstract][Full Text] [Related]
12. Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project.
Donal E; Lund L; Linde C; Daubert JC;
Arch Cardiovasc Dis; 2010; 103(6-7):404-10. PubMed ID: 20800804
[TBL] [Abstract][Full Text] [Related]
13. How do patients with heart failure with preserved ejection fraction die?
Chan MM; Lam CS
Eur J Heart Fail; 2013 Jun; 15(6):604-13. PubMed ID: 23610137
[TBL] [Abstract][Full Text] [Related]
14. Role of cardiopulmonary dysfunction and left atrial remodeling in development of acute decompensated heart failure in chronic heart failure with preserved left ventricular ejection fraction.
Kaneko H; Koike A; Senoo K; Tanaka S; Suzuki S; Nagayama O; Sagara K; Otsuka T; Matsuno S; Funada R; Uejima T; Oikawa Y; Yajima J; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
J Cardiol; 2012 May; 59(3):359-65. PubMed ID: 22421198
[TBL] [Abstract][Full Text] [Related]
15. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.
Maeder MT; Kaye DM
Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207
[TBL] [Abstract][Full Text] [Related]
16. Heart failure with preserved ejection fraction: an ongoing enigma.
Rose-Jones LJ; Rommel JJ; Chang PP
Cardiol Clin; 2014 Feb; 32(1):151-61, ix-x. PubMed ID: 24286586
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study.
Cleland JG; Taylor J; Freemantle N; Goode KM; Rigby AS; Tendera M
Eur J Heart Fail; 2012 May; 14(5):487-94. PubMed ID: 22505395
[TBL] [Abstract][Full Text] [Related]
18. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
[TBL] [Abstract][Full Text] [Related]
19. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.
Kato N; Kinugawa K; Shiga T; Hatano M; Takeda N; Imai Y; Watanabe M; Yao A; Hirata Y; Kazuma K; Nagai R
J Cardiol; 2012 Jul; 60(1):23-30. PubMed ID: 22445598
[TBL] [Abstract][Full Text] [Related]
20. Integration of exercise evaluation into the algorithm for evaluation of patients with suspected heart failure with preserved ejection fraction.
van Empel VP; Kaye DM
Int J Cardiol; 2013 Sep; 168(2):716-22. PubMed ID: 23711448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
